ASSESSING THE CAUSALITY OF GAMMA (IFN-G) AND IFN-G RECEPTOR 1/2 (IFNGR1/2) WITH SYSTEMIC LUPUS ERYTHEMATOSUS RISK USING GENETIC DATA

被引：0
|
作者：
Yao, K. X. [1 ,2 ]
Long, Y. Q. [1 ,2 ]
Qiao, L. L. [1 ,2 ]
Qiao, J. [1 ,2 ]
Zhang, S. X. [1 ,2 ]
Wang, C. [1 ,2 ]
Li, X. [1 ,2 ]
机构：
[1] Shanxi Med Univ, Hosp 2, Dept Rheumatol, Taiyuan, Peoples R China
[2] Shanxi Med Univ, Minist Educ, Key Lab Cellular Physiol, Taiyuan, Peoples R China
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Cytokines and chemokines; Genetics/epigenetics; Systemic lupus; erythematosus;
D O I：
10.1136/annrheumdis-2023-eular.1209
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS1411
引用
收藏
页码：1059 / 1059
页数：1
相关论文
共 35 条
  • [21] Interferon-gamma (IFN-G) producing human T cells directly induce osteoclastogenesis from human monocytes via the expression of RANKL: Possible role of TH1 cells in bone resorption
    Kotake, S
    Nanke, Y
    Ichikawa, N
    Furuya, T
    Mogi, M
    Togari, A
    Kamatani, N
    BONE, 2003, 32 (05) : S157 - S157
  • [22] In vivo neutralization of both interferon gamma (IFN-g) and interleukin-2 (IL-2) accelerates anti-host cytotoxic T lymphocyte (CTL) development and acute graft-versus-host disease (GVHD) in the parent-into-F1 model
    Puliaeva, IA
    Puliaev, RA
    Finkelaian, FD
    Via, CS
    CLINICAL IMMUNOLOGY, 2005, 115 : S63 - S63
  • [23] Clinical response to anti-ifn-gamma and anti-tnf-alpha in Th-1 and Th-1/th-2 diseases - Rheumatoid artiritis and systemic lupus erythematosus.
    Lukina, G.
    Sigidin, Ya.
    Pushkova, O.
    Skurkovich, B.
    Skurkovich, S.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S600 - S600
  • [24] Association of polymorphisms in Th1/Th2-related cytokines (IFN-g, TGFb1, IL-1b, IL-2, IL-4, IL-18) with oral lichen planus: A pooled analysis of case-control studies
    Liu, Wei
    Li, Meng
    Zhang, Xinzhong
    Zhou, Zengtong
    Shen, Zhengyu
    Shen, Xuemin
    JOURNAL OF DENTAL SCIENCES, 2023, 18 (02) : 560 - 566
  • [25] Different therapeutic responses after anti-interferon (IFN)-gamma therapy in Th1 (rheumatoid and psoriatic arthritis) and Th1/Th2 disease (systemic lupus erythematosus (SLE))
    Loukina, G
    Sigidin, Y
    Skurkovich, B
    Skurkovich, S
    JOURNAL OF LEUKOCYTE BIOLOGY, 2001, : 77 - 77
  • [26] G/T polymorphism in the interleukin-2 exon 1 region among Han Chinese systemic lupus erythematosus patients in Taiwan
    Lin, Ying-Ju
    Wan, Lei
    Sheu, Jim Jinn-Chyuan
    Huang, Chung-Ming
    Lin, Cheng-Wen
    Lan, Yu-Ching
    Lai, Chih-Ho
    Hung, Chien-Hui
    Tsai, Yuhsin
    Tsai, Chang-Hai
    Lin, Wei-Yong
    Liu, Hsin-Ping
    Lin, Ting-Hsu
    Huang, Yu-Min
    Tsai, Fuu-Jen
    CLINICAL IMMUNOLOGY, 2008, 129 (01) : 36 - 39
  • [27] LONG-TERM PRODUCTION OF INTERFERON GAMMA (IFN-G), TUMOR-NECROSIS-FACTOR (TNF) AND INTERLEUKIN-2 (IL-2) BY PERIPHERAL-BLOOD LYMPHOCYTES OF PATIENTS WITH MULTIPLE-SCLEROSIS (MS), MYASTHENIA-GRAVIS (MG) AND OTHER AUTOIMMUNE-DISEASES (OAD)
    GROB, D
    MOKHTARIAN, F
    FASEB JOURNAL, 1992, 6 (04): : A1048 - A1048
  • [28] FREQUENCY DISTRIBUTION OF CERTAIN SNPS POLYMORPHISMS OF IL-1A, I L1B, IL-2, IL-4, IL-6, IL-10, IL-12, IFN-G, TNF-A AND CTLA-4 ARE PRESENTED IN 203 HEALTHY MEXICAN MESTIZOS
    Garcia, David
    Alaez, Carmen
    Flores-A, Hilario
    Gorodezky, Clara
    TISSUE ANTIGENS, 2012, 79 (06): : 477 - 477
  • [29] THE INTERFERON-GAMMA-INDOLEAMINE 2,3-DIOXYGENASE 1 (IFN-G-IDO1) AXIS IS NOT INVOLVED IN THE MSC-MEDIATED IMMUNOSUPPRESSION OF ACTIVATED T CELL PROLIFERATION
    Harries, D. N.
    Samuel, K.
    Campbell, J.
    Mountford, J.
    CYTOTHERAPY, 2023, 25 (06) : S59 - S60
  • [30] TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH UPADACITINIB RESULTS IN THE COORDINATED INHIBITION OF TYPE 1 IFN-RELATED BIOMARKERS: BIOMARKER ANALYSIS OF THE M19130 (SLEEK) PHASE 2 STUDY
    Gaudreau, M. C.
    Fann, J.
    Contrepois, S.
    Friedman, A.
    Sornasse, T.
    Merrill, J. T.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 894 - 895
1234